Bridgeway Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-35,000
| Closed | -$534K | – | 1499 |
|
|
2018
Q3 | $534K | Sell |
35,000
-25,000
| -42% | -$381K | 0.01% | 1120 |
|
|
2018
Q2 | $735K | Sell |
60,000
-23,300
| -28% | -$285K | 0.01% | 1005 |
|
|
2018
Q1 | $796K | Sell |
83,300
-66,600
| -44% | -$636K | 0.01% | 924 |
|
|
2017
Q4 | $1.35M | Sell |
149,900
-18,400
| -11% | -$166K | 0.01% | 719 |
|
|
2017
Q3 | $968K | Buy |
168,300
+75,000
| +80% | +$431K | 0.01% | 854 |
|
|
2017
Q2 | $296K | Hold |
93,300
| – | – | ﹤0.01% | 1210 |
|
|
2017
Q1 | $317K | Hold |
93,300
| – | – | ﹤0.01% | 1199 |
|
|
2016
Q4 | $269K | Hold |
93,300
| – | – | ﹤0.01% | 1251 |
|
|
2016
Q3 | $549K | Buy |
+93,300
| New | +$549K | 0.01% | 1055 |
|
|
2016
Q2 | – | Sell |
-53,300
| Closed | -$286K | – | 1491 |
|
|
2016
Q1 | $286K | Sell |
53,300
-10,000
| -16% | -$53.7K | ﹤0.01% | 1224 |
|
|
2015
Q4 | $751K | Hold |
63,300
| – | – | 0.01% | 888 |
|
|
2015
Q3 | $520K | Buy |
63,300
+18,300
| +41% | +$150K | 0.01% | 1006 |
|
|
2015
Q2 | $628K | Hold |
45,000
| – | – | 0.01% | 960 |
|
|
2015
Q1 | $1.08M | Hold |
45,000
| – | – | 0.02% | 759 |
|
|
2014
Q4 | $741K | Buy |
+45,000
| New | +$741K | 0.02% | 891 |
|